Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab
Marco Iannetta, Novella Cesta, Christof Stingone, Vincenzo Malagnino, Elisabetta Teti, Pietro Vitale, Giuseppe De Simone, Benedetta Rossi, L Ansaldo, Mirko Compagno, Ilaria Spalliera, Andrea Di Lorenzo, Doriana Landi, Carolina Gabri Nicoletti, Girolama Alessandra Marfia, Massimo Andreoni, Loredana Sarmati
Topics & Concepts
OcrelizumabMedicineMultiple sclerosisCoronavirus disease 2019 (COVID-19)PneumoniaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakBetacoronavirusDermatologyVirologyInternal medicineImmunologyInfectious disease (medical specialty)DiseaseOutbreakRituximabLymphomaMultiple Sclerosis Research StudiesLong-Term Effects of COVID-19Peripheral Neuropathies and Disorders